Unibest

Pharmaceutical intermediates

Levosimendan Intermediates

1 pharmaceutical intermediate for Levosimendan. Indication: Heart failure.

提交项目All intermediates

About Levosimendan

Originator
Orion Corporation
Indication
Heart failure
Approved Date
09/22/2000

Available intermediates

1 intermediate currently listed for Levosimendan. Request specifications, documentation or a quotation for any item below.

Levosimendan intermediates
Product NameCAS No.Molecular FormulaPhysical Properties
6-(4-Aminophenyl)-4,5-dihydro-5-methyl-3(2H)-pyridazinone36725-28-7//

Other programs under L

(LCZ696)LanifibranorLapatinibLarotrectinibLasmiditanLazertinib MesylateLemborexantLenacapavir sodium

Building toward Levosimendan?

Tell us the step you need covered and the specification you are filing against. We will confirm supply, documentation and lead time.

提交项目 联系团队

我们能如何帮助您？

获取最新活动与法规动态洞察

直接发送到您的邮箱

在此获取行业洞察与 Unibest 动态

联系我们 →